who should take semaglutide Not Semaglutide? Understanding the Risks How Does Semaglutide Work? Mechanism,

Instead, you follow a gradual escalation designed to let your body adjust and minimize side effects

Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy

Switching medications should be done under the guidance of a healthcare provider

An additional 9 clinics offer cash-pay options for patients without coverage